Literature DB >> 29174957

Alternatives to Testosterone Therapy: A Review.

Eric M Lo1, Katherine M Rodriguez1, Alexander W Pastuszak2, Mohit Khera3.   

Abstract

INTRODUCTION: Although testosterone therapy (TTh) is an effective treatment for hypogonadism, recent concerns regarding its safety have been raised. In 2015, the US Food and Drug Administration issued a warning about potential cardiovascular risks resulting from TTh. Fertility preservation is another reason to search for viable alternative therapies to conventional TTh, and in this review we evaluate the literature examining these alternatives. AIMS: To review the role and limitations of non-testosterone treatments for hypogonadism.
METHODS: A literature search was conducted using PubMed to identify relevant studies examining medical and non-medical alternatives to TTh. Search terms included hypogonadism, testosterone replacement therapy, testosterone therapy, testosterone replacement alternatives, diet and exercise and testosterone, varicocele repair and testosterone, stress reduction and testosterone, and sleep apnea and testosterone. MAIN OUTCOME MEASURES: Review of peer-reviewed literature.
RESULTS: Medical therapies examined include human chorionic gonadotropins, aromatase inhibitors, and selective estrogen receptor modulators. Non-drug therapies that are reviewed include lifestyle modifications including diet and exercise, improvements in sleep, decreasing stress, and varicocele repair. The high prevalence of obesity and metabolic syndrome in the United States suggests that disease modification could represent a viable treatment approach for affected men with hypogonadism.
CONCLUSIONS: These alternatives to TTh can increase testosterone levels and should be considered before TTh. Lo EM, Rodriguez KM, Pastuszak AW, Khera M. Alternatives to Testosterone Therapy: A Review. Sex Med Rev 2018;6:106-113.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Aromatase Inhibitors; Human Chorionic Gonadotropin; Selective Estrogen Receptor Modulator; Testosterone; Testosterone Therapy; Varicocele

Mesh:

Substances:

Year:  2017        PMID: 29174957     DOI: 10.1016/j.sxmr.2017.09.004

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  16 in total

1.  Comparative effects of combined use of alcohol with cannabis and tobacco on testicular function in rats.

Authors:  Charles Obiora Nwonuma; Osarenkhoe Omorefosa Osemwegie; Emenike Onyebum Irokanulo; Omokolade Oluwaseyi Alejolowo; Omowumi Titilola Kayode; Tomilola Debby Olaolu; Adakole Sylvanus Ada; Damilare Emmanuel Rotimi; Roltdelmwa Filibus Maimako; Adeyinka Samuel Adedayo; Oluwafemi Adeleke Ojo
Journal:  Toxicol Res (Camb)       Date:  2021-06-29       Impact factor: 2.680

Review 2.  Investigating the basis of sexual dysfunction during late-onset hypogonadism.

Authors:  Tharu Tharakan; Saiful Miah; Channa Jayasena; Suks Minhas
Journal:  F1000Res       Date:  2019-03-25

Review 3.  Metabolic Disorders and Male Hypogonadotropic Hypogonadism.

Authors:  Rosario Pivonello; Davide Menafra; Enrico Riccio; Francesco Garifalos; Marco Mazzella; Cristina de Angelis; Annamaria Colao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-25       Impact factor: 5.555

4.  Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL.

Authors:  Vinayak Madhusoodanan; Premal Patel; Thiago Fernandes Negris Lima; Jabez Gondokusumo; Eric Lo; Nannan Thirumavalavan; Larry I Lipshultz; Ranjith Ramasamy
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

5.  Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members.

Authors:  Mohit Butaney; Nannan Thirumavalavan; Adithya Balasubramanian; J Abram McBride; Jabez Gondokusumo; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Urology       Date:  2020-02-08       Impact factor: 2.649

6.  Baseline Gonadotropin Levels and Testosterone Response in Hypogonadal Men Treated With Clomiphene Citrate.

Authors:  Sorena Keihani; Lindsey N Wright; Nathan J Alder; Jinfeng Jiang; Philip J Cheng; Gregory J Stoddard; Alexander W Pastuszak; Christopher M Deibert; James M Hotaling
Journal:  Urology       Date:  2020-04-28       Impact factor: 2.649

7.  Testosterone attenuates hypoxia-induced hypertension by affecting NRF1-mediated transcriptional regulation of ET-1 and ACE.

Authors:  Shan Jiang; Guijuan Chen; Zhihui Yang; Dan Wang; Yapeng Lu; Li Zhu; Xueting Wang
Journal:  Hypertens Res       Date:  2021-07-13       Impact factor: 3.872

8.  Lycopene Attenuates Hypoxia-Induced Testicular Injury by Inhibiting PROK2 Expression and Activating PI3K/AKT/mTOR Pathway in a Varicocele Adult Rat.

Authors:  Hongqiang Wang; Baojuan Zhu; Lei Yu; Qiang Li; Shenqian Li; Peitao Wang; Tao Jing; Tongyi Men
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-08       Impact factor: 2.629

9.  Elevated Body Mass Index Is Associated with Secondary Hypogonadism Among Men Presenting to a Tertiary Academic Medical Center.

Authors:  John M Masterson; Nachiketh Soodana-Prakash; Amir S Patel; Atil Y Kargi; Ranjith Ramasamy
Journal:  World J Mens Health       Date:  2018-10-10       Impact factor: 5.400

Review 10.  Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?

Authors:  Vito A Giagulli; Andrea Silvestrini; Carmine Bruno; Vincenzo Triggiani; Alvaro Mordente; Antonio Mancini
Journal:  Int J Endocrinol       Date:  2020-01-21       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.